Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Arthur V. Miller is active.

Publication


Featured researches published by Arthur V. Miller.


Bioorganic & Medicinal Chemistry Letters | 2008

2-Arylbenzoxazoles as novel cholesteryl ester transfer protein inhibitors: optimization via array synthesis.

Lalgudi S. Harikrishnan; Muthoni G. Kamau; Timothy Herpin; George C. Morton; Yalei Liu; Christopher B. Cooper; Mark E. Salvati; Jennifer X. Qiao; Tammy C. Wang; Leonard P. Adam; David S. Taylor; Alice Ye A. Chen; Xiaohong Yin; Ramakrishna Seethala; Tara L. Peterson; David S. Nirschl; Arthur V. Miller; Carolyn A. Weigelt; Kingsley K. Appiah; Jonathan O’Connell; R. Michael Lawrence

2-Arylbenzoxazole 5 was identified as a hit from a fluorescence-based high-throughput screen for CETP inhibitors. The synthesis and SAR investigation employing array synthesis of the A- and B-rings are described.


Journal of Medicinal Chemistry | 2012

Diphenylpyridylethanamine (DPPE) derivatives as cholesteryl ester transfer protein (CETP) inhibitors.

Lalgudi S. Harikrishnan; Heather Finlay; Jennifer X. Qiao; Muthoni G. Kamau; Ji Jiang; Tammy C. Wang; James C. B. Li; Christopher B. Cooper; Michael A. Poss; Leonard P. Adam; David S. Taylor; Alice Ye A. Chen; Xiaohong Yin; Paul G. Sleph; Richard Yang; Doree Sitkoff; Michael A. Galella; David S. Nirschl; Katy Van Kirk; Arthur V. Miller; Christine Huang; Ming Chang; Xue-Qing Chen; Mark E. Salvati; Ruth R. Wexler; R. Michael Lawrence

A series of diphenylpyridylethanamine (DPPE) derivatives was identified exhibiting potent CETP inhibition. Replacing the labile ester functionality in the initial lead 7 generated a series of amides and ureas. Further optimization of the DPPE series for potency resulted in the discovery of cyclopentylurea 15d, which demonstrated a reduction in cholesterol ester transfer activity (48% of predose level) in hCETP/apoB-100 dual transgenic mice. The PK profile of 15d was suboptimal, and further optimization of the N-terminus resulted in the discovery of amide 20 with an improved PK profile and robust efficacy in transgenic hCETP/apoB-100 mice and in hamsters. Compound 20 demonstrated no significant changes in either mean arterial blood pressure or heart rate in telemeterized rats despite sustained high exposures.


Bioorganic & Medicinal Chemistry Letters | 1992

Benzothiadiazine dioxides: A new class of potent angiotensin-II (AT1) receptor antagonists

Harold N. Weller; Arthur V. Miller; Robert V. Moquin; Kenneth E.J. Dickinson; S.Anders Hedberg; Suzanne Moreland; Robert Cohen; Carol L. Delaney; S. Skwish; Sharon Williams

Abstract N-Biphenylmethyl benzothiadiazine dioxides were prepared as potential angiotensin-II receptor antagonists. Stability of the compounds is dependent upon the nature of the substituent at position 3 of the benzothiadiazine ring, while potency is dependent upon the nature of substitution in the benzo fused ring. 3-(Propylthio)-4-[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-ylmethyl]-4H-1,2,4-benzothiadiazine-6-carboxylic acid, 1,1-dioxide ( 17 ) is one of the most potent examples, with functional activity (K B ) below 01 nM.


Bioorganic & Medicinal Chemistry Letters | 2011

Pyrrolo[1,2-f]triazines as JAK2 inhibitors: Achieving potency and selectivity for JAK2 over JAK3.

Lalgudi S. Harikrishnan; Muthoni G. Kamau; Honghe Wan; Jennifer Inghrim; Kurt Zimmermann; Xiaopeng Sang; Harold Mastalerz; Walter Lewis Johnson; Guifen Zhang; Louis J. Lombardo; Michael A. Poss; George L. Trainor; John S. Tokarski; Matthew V. Lorenzi; Dan You; Marco M. Gottardis; Kathy F. Baldwin; Jonathan Lippy; David S. Nirschl; Ruhui Qiu; Arthur V. Miller; Javed Khan; John S. Sack; Ashok V. Purandare

SAR studies of pyrrolo[1,2-f]triazines as JAK2 inhibitors is presented. Achieving JAK2 inhibition selectively over JAK3 is discussed.


Heterocycles | 1993

Synthesis of N-Alkyl-1,2,4-oxadiazinones as Angiotensin-II (AT1) Receptor Antagonists

Harold N. Weller; Arthur V. Miller; Kenneth E.J. Dickinson; S.Anders Hedberg; Carol L. Delaney; Randolph P. Serafino; Suzanne Moreland

4-Alkyl-1,2,4-oxadiazinones were prepared by regiospecific alkylation of the corresponding 4H-oxadiazinones, which were synthesized by a trimethylaluminium mediated cyclization reaction. Alkylation was regiospecific and generally facile; in one example, however, an unusual fragmentation reaction occurred. A homochiral oxadiazineone was also prepared and alkylated under the described conditions. 4-Biphenylmethyl-1,2,4-oxadi-azinones were potent angiotensin-II receptor antagonists


Tetrahedron Letters | 1996

Synthesis of 4-(N-alkyl-N-heteroaryl)amino-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile derivatives via an unusual 1,4-oxygen to nitrogen heteroaryl migration

Charles Z. Ding; Arthur V. Miller

Abstract Various heteroaryls were found to undergo 1,4-oxygen to nitrogen migration (e.g. 4→1 ) under acidic conditions. This unprecedented migratin provides a convenient access to 4-(N-alkyl-N-heteroaryl)amino-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile derivatives, which are otherwise difficult to prepare.


Journal of Medicinal Chemistry | 2000

Discovery of (R)-7-cyano-2,3,4, 5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3- (phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine (BMS-214662), a farnesyltransferase inhibitor with potent preclinical antitumor activity.

John T. Hunt; Charles Z. Ding; Roberta Batorsky; Mark S. Bednarz; Rajeev S. Bhide; Young H. Cho; Saeho Chong; Sam T. Chao; Johnni Gullo-Brown; Peng Guo; Soong Hoon Kim; Francis Y. Lee; Katerina Leftheris; Arthur V. Miller; Toomas Mitt; Manorama Patel; Becky Penhallow; Carol Ricca; William C. Rose; Robert J. Schmidt; William Allen Slusarchyk; Gregory D. Vite; Veeraswamy Manne


Journal of Medicinal Chemistry | 1993

Quinoxaline N-oxide containing potent angiotensin II receptor antagonists: synthesis, biological properties, and structure-activity relationships.

Kyoung S. Kim; Ligang Qian; J. E. Bird; Kenneth E.J. Dickinson; Suzanne Moreland; Thomas R. Schaeffer; Thomas L. Waldron; Carol L. Delaney; Harold N. Weller; Arthur V. Miller


Journal of Medicinal Chemistry | 1999

Discovery and Structure−Activity Relationships of Imidazole-Containing Tetrahydrobenzodiazepine Inhibitors of Farnesyltransferase.

Charles Z. Ding; Roberta Batorsky; Rajeev S. Bhide; Chao Hj; Young H. Cho; Chong S; Johnni Gullo-Brown; Peng Guo; Kim Sh; Francis Y. Lee; Katerina Leftheris; Arthur V. Miller; Toomas Mitt; Manorama Patel; Becky Penhallow; Carol Ricca; William C. Rose; Robert J. Schmidt; William Allen Slusarchyk; Gregory D. Vite; Ning Yan; Manne; John T. Hunt


Bioorganic & Medicinal Chemistry Letters | 2004

Benzodiazepine-based selective inhibitors of mitochondrial F1F0 ATP hydrolase

Lawrence G. Hamann; Charles Z. Ding; Arthur V. Miller; Cort S. Madsen; Paulina Wang; Philip D. Stein; Andrew T. Pudzianowski; David W. Green; Hossain Monshizadegan; Karnail S. Atwal

Collaboration


Dive into the Arthur V. Miller's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge